NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-031-2020-0-EG-17 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION EG National Stage PCT 1103/2022 Pending
NCI E-074-2020-1-SG-10 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION SG National Stage 11202251947C Pending
NIAID E-086-2020-0-US-03 SARS-COV-2 VACCINE US National Stage 17/798,021 Pending
NLM E-110-2016-2-RU-09 Novel CRISPR Enzymes And Systems RU DIV 2022-121427 Pending
NCATS E-168-2019-0-CA-04 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN
PLURIPOTENT STEM CELLS 		CA National Stage 3167242 Pending
NCI E-040-2012-0-MX-70 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen MX DIV MX/a/2022/009653 Pending
NCI E-074-2020-1-NZ-15 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION NZ National Stage 1979-10-24 Pending
NIDCR E-129-2021-0-PCT-02 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction PCT PCT PCT/US2022/074559 Expired
NCI E-226-2014-0-US-14 ANTI-THYROGLOBULIN T CELL RECEPTORS US CON 17/817,599 Pending
NCI E-074-2020-1-AU-03 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION AU National Stage 2021220957 Pending
NIDCR E-129-2021-0-HK-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction HK National Stage Pending
NINDS E-117-2021-1-PCT-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. PCT PCT COMB PCT/US2022/039245 Expired
NCI E-048-2021-0-PCT-02 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION PCT PCT PCT/US2022/074432
NCATS E-168-2019-0-EP-05 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN
PLURIPOTENT STEM CELLS 		EP National Stage 21712288.6 Pending
NCI E-176-2015-1-US-03 COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA US CON 17/816,656 11905564 Issued PDF
NCI E-176-2014-0-US-65 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS US CON 17/816,496 Pending
NCI E-031-2020-0-IL-18 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION IL National Stage 295252 Pending
NCI E-091-2019-0-EP-03 METHOD OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS EP National Stage 21705663.9 Pending
NCI E-107-2021-0-PCT-02 Use Of Tomentosenal A For Treatment Of Skin Conditions PCT PCT PCT/AU2022/050811 Expired
NCATS E-168-2019-0-AU-03 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN
PLURIPOTENT STEM CELLS 		AU National Stage 2021224724 Pending
NCATS E-168-2019-0-US-07 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN
PLURIPOTENT STEM CELLS 		US National Stage 17/796,044 Pending
NHLBI E-039-2022-0-PCT-02 TEMPERATURE CYCLING METHOD FOR HYPERPOLARIZATION OF TARGET MOLECULES AND CONTRAST AGENTS USING PARAHYDROGEN PCT PCT PCT/US2022/074122 Expired
NCI E-183-2017-0-EP-16 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains EP DIV 22187063.7 Pending
NCI E-265-2015-0-AU-35 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` AU DIV 2022209229 Pending
NCI E-099-2014-0-EP-14 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF EP DIV 22186683.3 Pending
NIAID E-203-2020-0-HK-11 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY HK EP 62022057259.3 Pending
NIBIB E-062-2017-0-US-08 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA
MULTIVIEW IMAGING 		US CON 17/814,096 1168-09-03 Issued PDF
NCI E-169-2018-0-US-06 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE US National Stage 17/794,212 Pending
NIAID E-007-2015-0-EP-37 CD47-targeted Therapies For The Treatment Of Infectious Disease EP DIV 22185801.2 Issued
NCI E-159-2019-0-US-06 HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) US National Stage 17/793,753 Pending
NCI E-159-2019-0-CA-03 HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) CA National Stage 3165251 Pending
NCI E-169-2018-0-CA-04 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE CA National Stage 3165120 Pending
NHLBI E-070-2020-0-US-05 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING US National Stage 17/793,089 Pending
NHLBI E-069-2020-0-US-05 REAL-TIME MONITORING OF INVIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES US National Stage 17/793,083 Pending
NEI E-251-2012-3-US-20 METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS) US DIV 17/812,915 Pending
NCI E-173-2018-2-GB-10 Viral Methods Of T Cell Therapy GB DIV 2210377.4 Issued
NCATS E-116-2016-0-CN-10 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE CN DIV 2022108264642 Pending
NCI E-169-2018-0-AU-03 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE AU National Stage 2021209875 Pending
NICHD E-173-2016-0-US-08 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS US CON 17/863,846 11846690 Issued PDF
NCI E-041-2020-0-US-03 Antisense Oligos That Block Cancer Cell Migration And Invasion US National Stage 17/792,507 Pending
NLM E-107-2010-2-US-37 METHODS OF EPIGENETIC ANALYSIS US CON 17/863,689 Abandoned
NLM E-110-2016-2-AU-01 Novel CRISPR Enzymes And Systems AU DIV 2022205165 Pending
NLM E-111-2016-7-AU-01 Novel CRISPR Enzymes And Systems AU DIV 2022205162 Pending
NEI E-164-2021-0-PCT-02 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY PCT PCT PCT/US2022/036420 Expired
NEI E-164-2021-0-US-03 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY US ORD 17/859,861 Pending
NIDCD E-029-2020-0-US-04 USE OF STATINS TO TREAT OR PREVENT DRUG INDUCED HEARING LOSS US National Stage 17/791,239 Pending
NIAID E-066-2014-0-EP-27 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF EP DIV 22183051.6 Pending
NCI E-091-2019-0-JP-04 METHOD OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS JP National Stage 2022-541714 Pending
NCI E-091-2019-0-US-05 METHODS OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS US National Stage 17/790,939 Pending
NCI E-175-2016-0-EP-19 ANTI-KRAS-G12D T CELL RECEPTORS EP DIV 22182473.3 Pending